Sepsis, Severe Infections and Stewardship pathway

Last updated : 18/06/2026 - 12383 views

Infection and sepsis remain major global health priorities and present specific challenges to intensive care practice. Building on ESICM’s education initiatives in infection management, sepsis, and antimicrobial stewardship (AMS), including LIVES workshops, fellowships, and digital learning modules, this programme delivers a hybrid model. It combines ESICM-led centralised activities (ensuring scientific quality and consistency) with decentralised, country-specific activities (supporting national adaptation and capacity building). AMS remains a cross-cutting priority aligned with EU and global health policy priorities.

Pathway directors

Andrew CONWAY MORRIS MD, PhD, MRC – Clinician Scientist, University of Cambridge; Honorary Consultant in Intensive Care Medicine, Addenbrookes Hospital, Cambridge, United Kingdom

Claire ROGER MD PhD – Head of Surgical Intensive Care Unit Anesthesia, Intensive Care, Pain and Emergency Department University Hospital Carémeau Nimes, University Nimes, France.

Programme overview

A structured ESICM education pathway combining centralised learning with country-tailored activities, supporting intensive care professionals in infection management, sepsis, and antimicrobial stewardship (AMS).

24-month programme (2026–2027)
Free access
Open to participants worldwide (priority access for selected activities in pilot countries). Registration details will be published in January 2026.

 Pathway timeline (2026–2027)
Key milestones across Levels 1–3 and faculty development activities.

What does the programme include?

Centralised activities (ESICM-led)

  • Self-paced e-learning across three progressive levels
  • Live online events and interactive learning
  • Activities at LIVES 2026 and LIVES 2027 (selected free entries available for pilot countries)
  • Fellowships & Expert Exchange opportunities across Europe
  • Faculty Development Days (FDD) for local ambassadors (pilot countries)

Decentralised activities (national hubs)

  • National Training Hubs in the pilot countries
  • National events and workshops linked to local and regional conferences
  • Hands-on simulation and bedside training sessions

Pilot phase: National Training Hubs

The pilot phase will run in five European countries: Poland, Portugal, Romania, Sweden, and the United Kingdom.
Participants from these countries receive priority access to selected onsite events and fellowship opportunities.

Level 1: Foundations in Sepsis and Severe Infections
Sepsis, Severe Infections and Stewardship pathway
7237 views
May 6, 2026 | Online
Level 2: Consolidating Clinical Practice
Sepsis, Severe Infections and Stewardship pathway
6126 views
September 9-10, 2026 | Online
Level 3: Developing Expert Practice
Sepsis, Severe Infections and Stewardship pathway
5948 views
2027 | Hybrid
Fellowships

A total of 20 Fellowships are offered in 2026. These opportunities are open to participants who have demonstrated sufficient attendance and assessment performance. Successful applicants will undertake fellowships in specific areas of the pathway, gaining bedside teaching from experts at globally renowned academic health sciences centres.

  • Duration: 1 week
  • Bursary: €1,000 to support travel and accommodation
  • Priority: Participants from the pilot countries will be prioritised

Centres and tutors:

  • University Hospital Southampton, Southampton, United Kingdom, Cathrine MCKENZIE , Kordo SAED and the local team. Dates: 16 – 20 November, 2026   
  • Radboud University Medical Centre, Nijmegen, The Netherlands, Jeroen SCHOUTEN and the local team.  Dates: 7 – 11 September, 2026      
  • Hospital de São Francisco Xavier, CHLO, Lisbon, Portugal, Pedro POVOA & Claudia MARTINS and the local team. Dates: 2 – 6 November, 2026         
  • University Hospital Carémeau Nimes,University Nimes, France, Claire ROGER and the local team. Dates: 16 – 20 November, 2026         

Eligibility and Application

  • Selection Criteria: Multi-professional delegations will be appointed by the leads of the pilot countries.
  • Final Selection: Decisions will be made by the leads of the pilot countries in alignment with the national societies, where applicable.
  • Membership:  Applicants must be members of ESICM (join now if you are not already a member).
Acknowledgement

Thanks to the unrestricted educational support from bioMérieux. The programme has not been influenced in any way by its sponsor.

Endorsement: The pathway is endorsed by the Infection Section, the Pharmacology and Pharmacotherapy Section, and the Systemic Inflammation and Sepsis Section, ESICM.

Further questions? Contact us at education@esicm.org

More resources for your clinical practice